0 citations
Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)
Annals of Hematology1998Vol. 77(1-2), pp. 89–91
Citations Over TimeTop 10% of 1998 papers
Related Papers
- → Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis(2018)32 cited
- → Chronic Lymphocytic Leukemia in the Dog(1980)16 cited
- → Tumor Lysis Syndrome as a Consequence of Chronic Lymphocytic Leukemia Treatment With Fludarabine and Rituximab(2011)2 cited
- → Promoting Tumor-Cell Death in Chronic Lymphocytic Leukemia(2016)
- → Tumor Lysis Syndrome as a Consequence of Chronic Lymphocytic Leukemia Treatment With Fludarabine and Rituximab(2011)